Mike Moyer
Investor Relations, Lakeside Advisors
Replay available
Protalix BioTherapeutics, Inc. (DE) (PLX) Q1 2026 Earnings Call
Protalix BioTherapeutics, Inc. (DE) (AMEX: PLX) Q1 2026 earnings conference call, held 2026-05-13. Replay captured from the company's public earnings webcast.
Hosted by
Featured presenters
Dror Bashan
President and CEO
Gilad Mamlach
Senior Vice President and Chief Financial Officer
Ram Surveju
Analyst, HC Wainwright
John Vandermeysen
Analyst, SACS
Investor webinar replay
Watch the replay and follow the connected company analysis, news, and investor updates for Protalix Biotherapeutics, Inc. (de).
Replay transcript excerpt
WEBVTT 00:00:00.031 -- 00:00:04.817 Good morning, ladies and gentlemen, and welcome to the Protallix Biotherapeutics First 00:00:04.817 -- 00:00:06.699 Quarter 2026 00:00:06.699 -- 00:00:09.703 Financial and Business Results Conference Call. 00:00:09.703 -- 00:00:12.547 As a reminder, this conference is being recorded. 00:00:12.547 -- 00:00:15.170 I will now turn the conference over to our host, Mr. 00:00:15.170 -- 00:00:19.535 Mike Moyer of Lakeside Advisors Investor Relations for Protallix. 00:00:19.535 -- 00:00:22.396 Thank you. Please go ahead. 00:00:22.739 -- 00:00:27.866 Thank you, Operator, and welcome to the Protallix Biotherapeutics Q1 2026 Financial 00:00:27.866 -- 00:00:30.237 Results and Business Update Conference Call. 00:00:30.237 -- 00:00:35.506 With me today are Dror Bashan, President and CEO of Portalix, and Gilad Mamlach, 00:00:35.506 -- 00:00:38.411 Senior Vice President and Chief Financial Officer. 00:00:38.411 -- 00:00:42.338 A press release announcing the financial results and corporate updates were issued this 00:00:42.338 -- 00:00:45.243 morning and are available now on the Portalix website. 00:00:45.243 -- 00:00:48.528 Please take a moment to read the disclaimer about forward-looking statements in the press 00:00:48.528 -- 00:00:52.850 release. The earnings release and this teleconference include forward-looking statements. 00:00:52.850 -- 00:00:56.875 These forward-looking statements are subject to known and unknown risks and uncertainties 00:00:56.875 -- 00:01:00.919 that may cause actual results to differ materially from the statements made. 00:01:00.919 -- 00:01:04.283 Factors that could cause actual results to differ are described in the disclaimer and 00:01:04.283 -- 00:01:07.908 in Bratalex's filings with the U.S. Securities and Exchan...